.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A systematic review of educational interventions designed to improve inhaler technique in asthma and COPD found that most interventions could produce a meaningful improvement in technique. The review included dozens of interventions delivered through different educational formats, with repeated evidence that clinician demonstration, patient re-demonstration, and structured education can change inhaler use. However, the effect was not always durable, and technique could deteriorate over time. The practical implication is highly relevant to routine respiratory care: inhaler technique should be checked repeatedly, especially when symptoms remain uncontrolled or when therapy is being escalated. Simply telling a patient how to use an inhaler at the time of first prescribing is rarely enough. For HCPs, the best workflow is usually teach–demonstrate–return-demonstrate–reinforce, with attention to the specific device the patient actually uses. The review supports the conference’s emphasis on correcting inhaler technique before stepping up therapy in airway disease. It also illustrates a broader principle of chronic respiratory medicine: implementation quality can determine whether a pharmacologically effective treatment produces the expected clinical benefit.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review of educational interventions designed to improve inhaler technique in asthma and COPD found that most interventions could produce a meaningful improvement in technique. The review included dozens of interventions delivered through different educational formats, with repeated evidence that clinician demonstration, patient re-demonstration, and structured education can change inhaler use. However, the effect was not always durable, and technique could deteriorate over time. The practical implication is highly relevant to routine respiratory care: inhaler technique should be checked repeatedly, especially when symptoms remain uncontrolled or when therapy is being escalated. Simply telling a patient how to use an inhaler at the time of first prescribing is rarely enough. For HCPs, the best workflow is usually teach–demonstrate–return-demonstrate–reinforce, with attention to the specific device the patient actually uses. The review supports the conference’s emphasis on correcting inhaler technique before stepping up therapy in airway disease. It also illustrates a broader principle of chronic respiratory medicine: implementation quality can determine whether a pharmacologically effective treatment produces the expected clinical benefit.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
